![\"\"](\"https:\/\/blogs.otago.ac.nz\/rainbow\/files\/2023\/03\/gaht-guideline-cover-1-216x300.jpg\")
<\/p>\nReleased in March 2023 to support primary care clinicians to initiate gender affirming hormone therapy (GAHT) for adults in a primary care setting.<\/p>\n
<\/p>\n
Primary Care GAHT Guidelines_Web_29 Mar<\/a><\/p>\n Endorsed by RNZCGP: The Royal New Zealand College of General Practitioners<\/span><\/p>\n Patient information sheets:<\/p>\n Primary Care GAHT Guidelines_Patient information sheet_Oestrogen<\/a><\/p>\n Primary Care <\/a>GAHT Guidelines_Patient information sheet_Testosterone<\/a><\/p>\n Injection guidance for health professionals:<\/p>\n Primary Care GAHT <\/a>Guidelines_Testosterone Administration<\/a><\/p>\n National guidelines for gender affirming care in Aotearoa can be found here:<\/p>\n https:\/\/patha.nz\/resources-and-training\/clinical-guidelines<\/a><\/p>\n A summary of the evidence and risks of using progesterone as part of E-GAHT – written for patients but shared here for clinicians to use if useful:<\/p>\n Progesterone patient info sheet for people taking E-GAHT <\/a><\/p>\n The primary care guidelines do not include oestrogen or testosterone gel as these were funded after the guidelines were developed. Information about prescribing these can be found here:<\/p>\n https:\/\/patha.nz\/resources-and-training\/clinical-guidelines<\/a><\/p>\n https:\/\/healthify.nz\/medicines-a-z\/o\/oestrogen-gender-affirming-hormone-therapy<\/a><\/p>\n![\"\"](\"https:\/\/blogs.otago.ac.nz\/rainbow\/files\/2023\/03\/RNZCGP_Endorsed_GUIDANCE_logo_Exp-30-Apr-2026.png\"){kind=logo}
<\/a><\/span><\/p>\nIndividual documents from the guideline\u00a0<\/strong><\/h4>\n
Updated guidelines for gender affirming healthcare in Aotearoa 2025<\/strong><\/h2>\n
Trans health peer support for GPs and NPs in Aotearoa:<\/strong><\/h2>\n
\n
<\/h4>\n
The following information sheets have been made to support healthcare professionals but are not part of the above guidelines:<\/strong><\/h4>\n